HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, ...

WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein ...

New research shows how a cellular nanomachine controls protein delivery, helping explain how small failures disrupt ...

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for ...

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...

WuXi Biologics says the company will provide the partnership with integrated, end-to-end biologics development and manufacturing services.

Taiwanese biotech HanchorBio (TPEx: 7827) has signed a strategic collaboration with WuXi Biologics (HKEX: 2269) to develop ...

We are pleased to welcome Matt to the executive team as we prepare for the potential commercial launch of atacicept for the ...

INCHEON, South Korea, Jan. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the ...

Nectins and Nectin-like (Necl) proteins are immunoglobulin-like adhesion molecules involved in cell–cell contact, synapse organization, and tissue ...

Purdue researchers identify the PACT protein as a potential target for triple-negative breast cancer, opening new paths for future treatments.